# Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis

> **NCT01948869** · NA · COMPLETED · sponsor: **Bayer** · enrollment: 35 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DEVICE:** Phoenix II (BAY81-2996)
- **DEVICE:** Phoenix I (BAY81-2996)

## Key facts

- **NCT ID:** NCT01948869
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948869, "Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01948869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*